{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:34:51Z","timestamp":1769268891593,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":68,"publisher":"Springer New York","isbn-type":[{"value":"9781493991983","type":"print"},{"value":"9781493991990","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9199-0_18","type":"book-chapter","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T11:02:53Z","timestamp":1553943773000},"page":"215-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Epidemiology and Biostatistics of Pneumococcus"],"prefix":"10.1007","author":[{"given":"Godwin","family":"Oligbu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman K.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,31]]},"reference":[{"key":"18_CR1","unstructured":"Russel F, Sanderson C, Temple B, Mulholand K (2011) Global review of the distribution of pneumococcal disease by age and region. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/immunization\/sage\/6_Russel_review_age_specific_epidemiology_PCV_schedules_session_novl 1.pdf . 2011.Nov"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/1469-0691.12461","volume":"20","author":"JJ Drijkoningen","year":"2014","unstructured":"Drijkoningen JJ, Rhode GG (2014) Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect 20:45\u201351","journal-title":"Clin Microbiol Infect"},{"issue":"RR-9","key":"18_CR3","first-page":"1","volume":"49","author":"Advisory Committee on Immunization Practices","year":"2000","unstructured":"Advisory Committee on Immunization Practices (2000) Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49(RR-9):1\u201335","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 1","key":"18_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/00002512-199915001-00002","volume":"15","author":"JC Butler","year":"1999","unstructured":"Butler JC, Schuchat A (1999) Epidemiology of pneumococcal infections in the elderly. Drugs Aging 15(Suppl 1):11\u201319","journal-title":"Drugs Aging"},{"issue":"9875","key":"18_CR5","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","volume":"381","author":"CL Walker","year":"2013","unstructured":"Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA et al (2013) Global burden of childhood pneumonia and diarrhoea. Lancet 381(9875):1405\u20131416","journal-title":"Lancet"},{"key":"18_CR6","unstructured":"World Health Organization (2008) Estimated Hib and pneumococcal deaths for children under 5 years of age. http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/estimates\/Pneumo_hib\/en \/. Accessed 12 May"},{"issue":"9693","key":"18_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O\u2019Brien","year":"2009","unstructured":"O\u2019Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N et al (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374(9693):893\u2013902","journal-title":"Lancet"},{"issue":"6","key":"18_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","volume":"16","author":"GA Mackenzie","year":"2016","unstructured":"Mackenzie GA, Hill PC, Jeffries DJ, Hossain I, Uchendu U, Ameh D et al (2016) Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study. Lancet Infect Dis 16(6):703\u2013711","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"18_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/14760584.2018.1413354","volume":"17","author":"P Izurieta","year":"2018","unstructured":"Izurieta P, Bahety P, Adegbola R, Clarke C, Hoet B (2018) Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Rev Vaccines 17(6):479\u2013493","journal-title":"Expert Rev Vaccines"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1086\/379016","volume":"37","author":"MH Kyaw","year":"2003","unstructured":"Kyaw MH, Christie P, Clarke SC, Mooney JD, Ahmed S, Jones IG et al (2003) Invasive pneumococcal disease in Scotland, 1999\u20132001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 37:1283\u20131291","journal-title":"Clin Infect Dis"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1469-0691.2005.01282.x","volume":"11","author":"RR Reinert","year":"2005","unstructured":"Reinert RR, Haupts S, van der LM HC, Cil MY, Al-Lahham A et al (2005) Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001\u20132003. Clin Microbiol Infect 11:985\u2013991","journal-title":"Clin Microbiol Infect"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0029-1202938","volume":"30","author":"JP Lynch","year":"2009","unstructured":"Lynch JP, Zhanel GG (2009) Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 30:189\u2013209","journal-title":"Semin Respir Crit Care Med"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1086\/425615","volume":"39","author":"ML Jackson","year":"2004","unstructured":"Jackson ML, Neuzil KM, Thomson WW et al (2004) The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 39:1642\u20131650","journal-title":"Clin Infect Dis"},{"issue":"6","key":"18_CR14","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1183\/09031936.05.00030205","volume":"26","author":"A Vila-Corcoles","year":"2005","unstructured":"Vila-Corcoles A, Ochoa-Gondar O, Llor C, Rodr\u00edguez T, G\u00f3mez A (2005) Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. Eur Respir J 26(6):1086\u20131091","journal-title":"Eur Respir J"},{"issue":"3 Pt 1","key":"18_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1164\/ajrccm.163.3.2005075","volume":"163","author":"AA El-Solh","year":"2001","unstructured":"El-Solh AA, Sikka P, Ramadan F, Davies J (2001) Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 163(3 Pt 1):645\u2013651","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"18_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.vhri.2013.07.003","volume":"2","author":"N Maimaiti","year":"2013","unstructured":"Maimaiti N, Ahmed Z, Isa ZM, Ghazi HF, Aljunid S (2013) Clinical burden of invasive pneumococcal disease in selected developing countries. Value Health Reg Issues 2(2):259\u2013263","journal-title":"Value Health Reg Issues"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1016\/j.vaccine.2010.05.030","volume":"28","author":"D Weycker","year":"2010","unstructured":"Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA (2010) Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 28:4955\u20134960","journal-title":"Vaccine"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","volume":"29","author":"SS Huang","year":"2011","unstructured":"Huang SS, Johnson KM, Ray GT et al (2011) Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 29:3398\u20133412","journal-title":"Vaccine"},{"key":"18_CR19","volume-title":"Lung Health in Europe Facts and Figures","author":"GJ Gibson","year":"2003","unstructured":"Gibson GJ, Loddenkemper R, Sibille Y, European Respiratory Society\/European Lung Foundation (2003) Lung Health in Europe Facts and Figures. ERSJ, Sheffield"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","volume":"32","author":"SM Davis","year":"2013","unstructured":"Davis SM, Deloria-Knoll M, Kassa HT, O\u2019Brien KL (2013) Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 32:133\u2013145","journal-title":"Vaccine"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1016\/j.vaccine.2005.08.100","volume":"23","author":"TW Hennessy","year":"2005","unstructured":"Hennessy TW, Singleton RJ, Bulkow LR et al (2005) Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine 23:5464\u20135473","journal-title":"Vaccine"},{"key":"#cr-split#-18_CR22.1","unstructured":"Cohen R, Levy C, Bingen E, Bonnet E, Koskas M, Attal S, et al (2011) Impact of 13-valent pneumococcal conjugate vaccine (PCV13) on nasopharyngeal"},{"key":"#cr-split#-18_CR22.2","unstructured":"(NP) flora in children with acute otitis media (AOM). In: Presented at the 51st ICAAC, September 17-20, 2011, Chicago, USA"},{"issue":"Suppl 2 Optimum","key":"18_CR23","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1097\/INF.0000000000000078","volume":"33","author":"L Conklin","year":"2014","unstructured":"Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE et al (2014) Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J 33(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supporting Different Schedules):S109\u2013S118","journal-title":"Pediatr Infect Dis J"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","volume":"32","author":"SL Kaplan","year":"2013","unstructured":"Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ et al (2013) Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 32:203\u2013207","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"18_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","volume":"15","author":"PA Waight","year":"2015","unstructured":"Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MPE, Miller E (2015) Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 15(5):535\u2013543","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"18_CR26","first-page":"18","volume":"32","author":"R Gilmour","year":"2008","unstructured":"Gilmour R, Holland R, Kampen R, Brown M, Gilbert L, Hogg G et al (2008) Invasive pneumococcal disease in Australia, 2006. Commun Dis Intell 32(1):18\u201330","journal-title":"Commun Dis Intell"},{"issue":"10","key":"18_CR27","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1503\/cmaj.051150","volume":"173","author":"JD Kellner","year":"2005","unstructured":"Kellner JD, Church DL, MacDonald J, Tyrrell GJ, Scheifele D (2005) Progress in the prevention of pneumococcal infection. Can Med Assoc J 173(10):1149\u20131151","journal-title":"Can Med Assoc J"},{"issue":"3","key":"18_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1586\/erv.11.1","volume":"10","author":"TT Zangeneh","year":"2011","unstructured":"Zangeneh TT, Baracco G, Al-Tawfiq JA (2011) Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections. Expert Rev Vaccines 10(3):345\u2013353","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"18_CR29","first-page":"93","volume":"82","author":"World Health Organization position paper - Pneumococcal conjugate vaccine for childhood immunization","year":"2007","unstructured":"World Health Organization position paper - Pneumococcal conjugate vaccine for childhood immunization (2007) WHO position paper. Wkly Epidemiol Rec 82(12):93\u2013104","journal-title":"Wkly Epidemiol Rec"},{"issue":"2","key":"18_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12325-013-0007-6","volume":"30","author":"TT Myint","year":"2013","unstructured":"Myint TT, Madhava H, Balmer P, Christopoulou D, Attal S, Menegas D et al (2013) The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review. Adv Ther 30(2):127\u2013151","journal-title":"Adv Ther"},{"issue":"10","key":"18_CR31","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","volume":"11","author":"E Miller","year":"2011","unstructured":"Miller E, Andrews NJ, Waight PA, Slack MPE, George RC (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11(10):760\u2013768","journal-title":"Lancet Infect Dis"},{"issue":"9807","key":"18_CR32","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","volume":"378","author":"DM Weinberger","year":"2011","unstructured":"Weinberger DM, Malley RLM (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378(9807):1962\u20131973","journal-title":"Lancet"},{"issue":"16","key":"18_CR33","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","volume":"297","author":"RJ Singleton","year":"2007","unstructured":"Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA et al (2007) Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297(16):1784\u20131792","journal-title":"JAMA"},{"issue":"3","key":"18_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jpeds.2009.10.008","volume":"158","author":"SY Park","year":"2010","unstructured":"Park SY, Van Beneden CA, Pilishvili T, Martin M, Facklam RR, Whitney CG (2010) Invasive pneumococcal infections among vaccinated children in the United States active bacterial core surveillance team. J Pediatr 158(3):478\u2013483.e2","journal-title":"J Pediatr"},{"issue":"36","key":"18_CR35","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1016\/j.vaccine.2017.05.059","volume":"36","author":"S Ben-Shimol","year":"2017","unstructured":"Ben-Shimol S, Givon-Lavi N, Grisaru-Soen G, Megged O, Greenberg D, Dagan R (2017) Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies. Vaccine 36(36):5477\u20135484","journal-title":"Vaccine"},{"issue":"1","key":"18_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12916-016-0755-7","volume":"14","author":"A Alari","year":"2016","unstructured":"Alari A, Chaussade H, Domenech De Cell\u00e8s M, Le Fouler L, Varon E, Opatowski L et al (2016) Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis. BMC Med 14(1):211","journal-title":"BMC Med"},{"issue":"3","key":"18_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","volume":"360","author":"HE Hsu","year":"2009","unstructured":"Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS et al (2009) Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 360(3):244\u2013256","journal-title":"N Engl J Med"},{"issue":"35 Pt B","key":"18_CR38","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1016\/j.vaccine.2017.06.070","volume":"35","author":"J Ruiz-Contreras","year":"2017","unstructured":"Ruiz-Contreras J, Picazo J, Casado-Flores J, Baquero-Artigao F, Hern\u00e1ndez-Sampelayo T, HERACLES STUDY GROUP et al (2017) Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children. Vaccine 35(35 Pt B):4646\u20134651","journal-title":"Vaccine"},{"issue":"11","key":"18_CR39","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1086\/587897","volume":"46","author":"CJ Tsai","year":"2008","unstructured":"Tsai CJ, Griffin MR, Nuorti JP, Grijalva GC (2008) Changing epidemiology of pneumococcal meningitis after introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 46(11):1664\u20131672","journal-title":"Clin Infect Dis"},{"issue":"5","key":"18_CR40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/cid\/civ368","volume":"61","author":"L Olarte","year":"2015","unstructured":"Olarte L, Barson WJ, Barson RM, Lin PL, Romero JR, Tan TQ et al (2015) Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clin Infect Dis 61(5):767\u2013775","journal-title":"Clin Infect Dis"},{"issue":"5","key":"18_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1586\/14787210.6.5.619","volume":"6","author":"M Jacobs","year":"2008","unstructured":"Jacobs M (2008) Antimicrobial-resistant streptococcus pneumoniae: trends and management. Expert Rev Anti-Infect Ther 6(5):619\u2013635","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"12","key":"18_CR42","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1086\/593339","volume":"198","author":"IH Park","year":"2008","unstructured":"Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B et al (2008) Active bacteria core surveillance team. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 198(12):1818\u20131822","journal-title":"J Infect Dis"},{"issue":"6","key":"18_CR43","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","volume":"26","author":"SI Pelton","year":"2007","unstructured":"Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J et al (2007) Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 26(6):468\u2013472","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"18_CR44","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1086\/498043","volume":"192","author":"R Pai","year":"2005","unstructured":"Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B (2005) Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192(11):1988\u20131995","journal-title":"J Infect Dis"},{"issue":"10","key":"18_CR45","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/INF.0b013e3182615615","volume":"31","author":"I Yildirim","year":"2012","unstructured":"Yildirim I, Stevenson A, Hsu KK, Pelton SI (2012) Evolving picture of invasive pneumococcal disease in Massachusetts children: a comparison of disease in 2007\u20132009 with earlier periods. Pediatr Infect Dis J 31(10):1016\u20131021","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"18_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/INF.0b013e318233049d","volume":"31","author":"OG Vanderkooi","year":"2012","unstructured":"Vanderkooi OG, Scheifele DW, Girgenti D, Halperin SA, Patterson SD, Gruber WC et al (2012) Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada. Pediatr Infect Dis J 31(1):72\u201377","journal-title":"Pediatr Infect Dis J"},{"key":"18_CR47","unstructured":"European Centre for Disease Prevention and Control (2017) Invasive pneumococcal disease. Stockholm. https:\/\/ecdc.europa.eu\/en\/publications-data\/invasive-pneumococcal-disease-annual-epidemiological-report-2017 . Accessed 12 May 2018"},{"key":"18_CR48","unstructured":"World Health Organization, UNICEF (2013) Ending preventable child deaths from pneumonia and diarrhoea by 2025: The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD)"},{"issue":"17","key":"18_CR49","first-page":"1","volume":"3099","author":"C Troeger","year":"2017","unstructured":"Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A, Reiner RC Jr et al (2017) Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis 3099(17):1\u201340","journal-title":"Lancet Infect Dis"},{"key":"18_CR50","first-page":"CD004977","volume":"4","author":"M Lucero","year":"2009","unstructured":"Lucero M, Dulalia V, Nillos L, Williams G, Parre\u00f1o R, Nohynek H et al (2009) Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev 4:CD004977","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"18_CR51","first-page":"139","volume":"113","author":"H Ewald","year":"2016","unstructured":"Ewald H, Briel M, Vuichard D, Kreutle V, Zhydkov A, Gloy V (2016) The clinical effectiveness of pneumococcal conjugate vaccines: a systematic review and metaanalysis of randomized controlled trials. Dtsch Arztebl Int 113(9):139\u2013146","journal-title":"Dtsch Arztebl Int"},{"issue":"26","key":"18_CR52","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","volume":"343","author":"CG Whitney","year":"2000","unstructured":"Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A et al (2000) Active bacterial core surveillance program of the emerging infections program network. Increasing prevalence of multidrug-resistant streptococcus pneumoniae in the United States. N Engl J Med 343(26):1917\u20131924","journal-title":"N Engl J Med"},{"issue":"7","key":"18_CR53","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3201\/eid1907.121830","volume":"19","author":"SS Richter","year":"2013","unstructured":"Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV (2013) Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999\u20132011. Emerg Infect Dis 19(7):1074\u20131083","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"18_CR54","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3201\/eid1609.100102","volume":"16","author":"G Hanquet","year":"2010","unstructured":"Hanquet G, Kissling E, Fenoll A, George R, Lepoutre A, Lernout T et al (2010) Pneumococcal serotypes in children in 4 European countries. Emerg Infect Dis 16(9):1428\u20131439","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"18_CR55","doi-asserted-by":"publisher","first-page":"ofw020","DOI":"10.1093\/ofid\/ofw020","volume":"3","author":"C Janoir","year":"2016","unstructured":"Janoir C, Lepoutre A, Gutmann L, Varon E (2016) Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent Pneumococcal conjugate vaccine implementation in France. Open Forum Infect Dis 3(1):ofw020","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"18_CR56","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1128\/JCM.01547-08","volume":"47","author":"F Mahjoub-Messai","year":"2009","unstructured":"Mahjoub-Messai F, Doit C, Koeck JL, Billard T, Evrard B, Bidet P et al (2009) Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal vaccination for French children. J Clin Microbiol 47(3):837\u2013840","journal-title":"J Clin Microbiol"},{"key":"18_CR57","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/cid\/ciu431","volume":"59","author":"C Cohen","year":"2014","unstructured":"Cohen C, von Mollendorf C, de Gouveia L, Naidoo N, Meiring S, Quan V et al (2014) Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in South Africa: a matched case-control study. Clin Infect Dis 59:808\u2013818","journal-title":"Clin Infect Dis"},{"issue":"20","key":"18_CR58","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","volume":"371","author":"A Gottberg Von","year":"2014","unstructured":"Von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, Von Mollendorf C et al (2014) Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med 371(20):1889\u20131899","journal-title":"N Engl J Med"},{"key":"18_CR59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","volume":"4","author":"MR Moore","year":"2016","unstructured":"Moore MR, Link-Gelles R, Schaffner W et al (2016) Effectiveness of 13- valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case- control study. Lancet Respir Med 4:399\u2013406","journal-title":"Lancet Respir Med"},{"issue":"10","key":"18_CR60","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","volume":"16","author":"R Isturiz","year":"2017","unstructured":"Isturiz R, Sings HL, Hilton B, Arguedas A, Reinert RR, Jodar L (2017) Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert Rev Vaccines 16(10):1007\u20131027","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"18_CR61","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jpids\/piw005","volume":"6","author":"CL Gaviria-Agudelo","year":"2017","unstructured":"Gaviria-Agudelo CL, Jordan-Villegas A, Garcia C, McCracken GH Jr (2017) The effect of 13-valent pneumococcal conjugate vaccine on the serotype distribution and antibiotic resistance profiles in children with invasive pneumococcal disease. J Pediatr Infect Dis Soc 6(3):253\u2013259","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"5","key":"18_CR62","doi-asserted-by":"publisher","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","volume":"12","author":"E Balsells","year":"2017","unstructured":"Balsells E, Guillot L, Nair H, Kyaw MH (2017) Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS One 12(5):e0177113","journal-title":"PLoS One"},{"key":"18_CR63","first-page":"822","volume":"63","author":"S Tomczyk","year":"2014","unstructured":"Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Centre for Disease Control and Prevention (CDC) et al (2014) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 63:822\u2013825","journal-title":"Morb Mortal Wkly Rep"},{"issue":"25","key":"18_CR64","first-page":"521","volume":"62","author":"I Persons","year":"2013","unstructured":"Persons I (2013) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6\u201318 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 62(25):521","journal-title":"Morb Mortal Wkly Rep"},{"key":"18_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1503\/cmaj.080734","volume":"180","author":"A Huss","year":"2009","unstructured":"Huss A, Scott P, Stuck AE, Trotter C, Egger M (2009) Efficacy of pneumococcal vaccination in adults: a meta-analysis. Can Med Assoc J 180:48\u201358","journal-title":"Can Med Assoc J"},{"key":"18_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1586\/erv.11.8","volume":"10","author":"J Poolman","year":"2011","unstructured":"Poolman J, Borrow R (2011) Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines 10:307\u2013322","journal-title":"Expert Rev Vaccines"},{"key":"18_CR67","unstructured":"VIEW-hub [Internet]. PCV: Current vaccine intro status. [Cited 2018 May12]. http:\/\/view-hub.org\/viz\/"}],"container-title":["Methods in Molecular Biology","Streptococcus pneumoniae"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9199-0_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T22:14:25Z","timestamp":1663193665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9199-0_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493991983","9781493991990"],"references-count":68,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9199-0_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"31 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}